Nuo Nova Yang, a scientist at an American Cancer Society research center, and colleagues have come up with indirect evidence that cancer screening benefits might have an effect on how likely people are to beat cancer.
With full access to their data, mid-market employers are empowered to change the carrier’s narrative about their risk posture and its role in rate increases and shape their own vision.
“Benefits provide employees with stability and protection in uncertain times, which helps them feel cared for and amplifies trust,” Todd Katz, head of group benefits for MetLife, said.
Current and former employees are suing JPMorgan, alleging that it allows inflated drug prices through its partnership with its pharmacy benefit manager, CVS Caremark.